Drug Shortage Report for HYDROXYZINE
Report ID | 196837 |
Drug Identification Number | 00646016 |
Brand name | HYDROXYZINE |
Common or Proper name | HYDROXYZINE |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYZINE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | N05BB |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-06-29 |
Actual start date | |
Estimated end date | 2023-08-11 |
Actual end date | 2023-08-08 |
Shortage status | Resolved |
Updated date | 2023-08-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-08-14 | French | Compare |
v6 | 2023-08-14 | English | Compare |
v5 | 2023-07-31 | French | Compare |
v4 | 2023-07-31 | English | Compare |
v3 | 2023-06-30 | English | Compare |
v2 | 2023-06-29 | French | Compare |
v1 | 2023-06-29 | English | Compare |
Showing 1 to 7 of 7